This 2012 paper used lung-tissue gene-expression analysis, computational screening, and fibroblast experiments to investigate disease-associated patterns. It did not administer GHK to patients to test improvement in breathing or disease progression. Primary study
What was measured
The tissue analysis included 64 regional samples from eight lungs. Investigators identified an emphysema-associated expression pattern, used the Connectivity Map to identify GHK as a candidate for reversing that pattern, and tested related responses in fibroblasts. They reported changes in expression and cell-remodeling measurements. The authors called for further work on mechanisms and disease progression. Primary study
Samples are not the same as participants
Our appraisal treats the distinction between 64 specimens and eight lungs as essential. Several specimens from one source can provide information about regional differences without becoming independent people. A summary that silently replaces the tissue count with a patient count would misdescribe the study.
For an original analogy, eight maps can each contain eight observation points. That provides 64 locations, but not 64 separate landscapes. In research, the analysis must respect where measurements came from and which sources they share.
A reversed signature is a research lead
Computational matching can prioritize a hypothesis for testing. It does not transform a pattern into a demonstrated treatment effect. Our reading question is: which parts of the chain were directly measured, which were inferred, and which remain future work?
| Step | Evidence question |
|---|---|
| Tissue profiling | How were disease severity and expression related? |
| Computational matching | What pattern qualified a candidate for further study? |
| Cell experiment | Which specific response was tested independently? |
| Clinical claim | Were symptoms, function, or progression actually evaluated? |
The material's identity also matters. Do not substitute the name GHK-Cu for GHK without checking what the experiment actually used and how copper complexation was addressed. The site may discuss both entities, but a study summary must preserve the source's material description.
Frequently asked questions
Was this a COPD treatment trial?
No. It was tissue-based, computational, and cellular research.
Were 64 patients studied?
The reported number refers to regional samples from eight lungs.
Does a reversed gene signature mean damaged lungs regrew?
No. That is a much broader claim than the reported measurements.
Is a fibroblast response a lung-function test?
No. Those are different endpoints.
Can the GHK name be replaced with GHK-Cu?
Not without checking the tested material and its chemical context.
Does the paper validate a catalog product?
No. It does not establish another material's identity or performance.
What remains unresolved in this appraisal?
Full methods, specimen selection, analysis details, disclosures, material specification, and current publication notices require final review.